Liver fatty acid binding protein FABP1 transfers substrates to cytochrome P450 4A11 for catalysis.

J Biol Chem

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States. Electronic address:

Published: January 2025

Cytochrome P450 (P450) 4A11 is a human P450 family 4 ω-oxidase that selectively catalyzes the hydroxylation of the terminal methyl group of fatty acids. Cytosolic lipids are the substrates for the enzyme but are considered to be primarily bound in cells by liver fatty acid binding protein (FABP1). Lipid binding to recombinant FABP1 with a fluorophore displacement assay showed substantial preference of FABP1 for ≥16-carbon fatty acids (K < 70 nM). Comparison of palmitate binding studies revealed that FABP1 bound the lipid >100-fold more tightly than P450 4A11. Tight binding of P450 4A11 to Alexa-488 dye-labeled FABP1 was observed in fluorescence assays, and the interaction was dependent on ionic strength (K 3-124 nM). Kinetic studies with Alexa-FABP1 indicated that the rate of protein-protein association is fast (∼2 s), and a palmitate delivery experiment suggested that substrate transfer (from FABP1 to P450) is not rate-limiting. From these results we constructed a kinetic model of the FABP1-P450 interaction and applied it to a catalytic study of FABP1 on P450 4A11 palmitate ω-hydroxylation, the results of which conclusively rejected the free ligand hypothesis. Our results are explained by a direct transfer model in which lipid-bound FABP1 interacts with P450 4A11, transfers the substrate, and a slower P450 conformational change follows to position the molecule in a mode for oxidation. Given the limited free lipid pool in vivo, interaction with FABP1 may be a dominant mechanism by which P450 4A11 accesses its substrates and may offer a novel means to target P450 4A11 activity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbc.2025.108168DOI Listing

Publication Analysis

Top Keywords

p450 4a11
32
p450
12
fabp1
10
liver fatty
8
fatty acid
8
acid binding
8
binding protein
8
protein fabp1
8
cytochrome p450
8
4a11
8

Similar Publications

Liver fatty acid binding protein FABP1 transfers substrates to cytochrome P450 4A11 for catalysis.

J Biol Chem

January 2025

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States. Electronic address:

Cytochrome P450 (P450) 4A11 is a human P450 family 4 ω-oxidase that selectively catalyzes the hydroxylation of the terminal methyl group of fatty acids. Cytosolic lipids are the substrates for the enzyme but are considered to be primarily bound in cells by liver fatty acid binding protein (FABP1). Lipid binding to recombinant FABP1 with a fluorophore displacement assay showed substantial preference of FABP1 for ≥16-carbon fatty acids (K < 70 nM).

View Article and Find Full Text PDF

Age-Dependent Changes in Cytochrome P450 Abundance and Composition in Human Liver.

Drug Metab Dispos

November 2024

Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington

Cytochrome P450 (CYP) superfamily represents the major drug-metabolizing enzymes responsible for metabolizing over 65% of therapeutic drugs, including those for pediatric use. CYP-ontogeny based physiologically based pharmacokinetic (PBPK) modeling has emerged as useful approach to mechanistically extrapolate adult pharmacokinetic data to children. However, these models integrate physiological differences in the pediatric population including age-dependent differences in the abundances of CYP enzymes.

View Article and Find Full Text PDF

Investigation of Functional Cytochrome P450 4A Enzymes in Liver and Kidney of Pigs, Cats, Tree Shrews, and Dogs in Comparison with the Metabolic Capacity of Human P450 4A11.

Drug Metab Dispos

August 2024

Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima City, Kagoshima, Japan (Y.U., K.T.-K.); Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan (M.I.); Graduate School of Agriculture, Ehime University, Matsuyama, Ehime, Japan (H.M.); and Showa Pharmaceutical University, Machida, Tokyo, Japan (N.M., H.Y.)

Pigs are sometimes used in preclinical drug metabolism studies, with growing interest, and thus their drug-metabolizing enzymes, including the cytochromes P450 (P450 or CYP; EC 1.14.14.

View Article and Find Full Text PDF

Cytochrome P450 Enzymes as Drug Targets in Human Disease.

Drug Metab Dispos

May 2024

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee

Although the mention of cytochrome P450 (P450) inhibition usually brings to mind unwanted variability in pharmacokinetics, in several cases P450s are good targets for inhibition. These P450s are essential, but in certain disease states, it is desirable to reduce the concentrations of their products. Most of the attention to date has been with human P450s 5A1, 11A1, 11B1, 11B2, 17A1, 19A1, and 51A1.

View Article and Find Full Text PDF

Effects of acidic non-steroidal anti-inflammatory drugs on human cytochrome P450 4A11 activity: Roles of carboxylic acid and a sulfur atom in potent inhibition by sulindac sulfide.

Chem Biol Interact

September 2023

Department of Pharmacy, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, 390-8621, Japan; Department of Biochemical Pharmacology and Toxicology, Graduate School of Medicine, Shinshu University, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. Electronic address:

Cytochrome P450 4A11 (CYP4A11) has many endogenous and exogenous compounds containing a carboxyl group in their structure as substrates. If drugs with this characteristic potently attenuate the catalytic function of CYP4A11, drug-drug interactions may occur. Acidic non-steroidal anti-inflammatory drugs (NSAIDs) possess a carboxylic acid in their structure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!